Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
34
FCNCA Quote, Financials, Valuation and Earnings
Last price:
$1,775.93
Seasonality move
:
3.25%
Day range:
$1,760.98 - $1,802.74
52-week range:
$1,473.62 - $2,412.93
Dividend yield:
0.4%
P/E ratio:
10.27x
P/S ratio:
2.65x
P/B ratio:
1.12x
Volume:
48.6K
Avg. volume:
111.2K
1-year change:
5.01%
Market cap:
$24.1B
Revenue:
$9.7B
EPS (TTM):
$174.64
Analysts' Opinion
-
Consensus RatingFirst Citizens BancShares has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $2,191.25, First Citizens BancShares has an estimated upside of 22.21% from its current price of $1,793.05.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1,900.00 representing -5.97% downside risk from its current price of $1,793.05.
Fair Value
-
According to the consensus of 7 analysts, First Citizens BancShares has 22.21% upside to fair value with a price target of $2,191.25 per share.
FCNCA vs. S&P 500
-
Over the past 5 trading days, First Citizens BancShares has overperformed the S&P 500 by 1.96% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
First Citizens BancShares does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
First Citizens BancShares revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter First Citizens BancShares reported revenues of $2.3B.
Earnings Growth
-
First Citizens BancShares earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter First Citizens BancShares reported earnings per share of $34.47.
Enterprise value:
3.9B
EV / Invested capital:
0.06x
Price / LTM sales:
2.65x
EV / EBIT:
0.47x
EV / Revenue:
0.41x
PEG ratio (5yr expected):
--
EV / Free cash flow:
2.71x
Price / Operating cash flow:
17.68x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
1.14%
Net Income Margin (TTM):
26.54%
Return On Equity:
11.32%
Return On Invested Capital:
4.25%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $4.8B | $10B | $9.5B | $2.4B | $2.3B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $704.45 | $180.13 | $174.64 | $49.26 | $34.47 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $15.5B | $21.3B | $53.1B | $60.6B | $61.8B | |
| Total Assets | $53.9B | $108.6B | $214.7B | $217.8B | $228.8B | |
| Current Liabilities | $680.7M | $616M | $1B | $1.1B | $450M | |
| Total Liabilities | $49.6B | $98B | $195.4B | $196B | $206.5B | |
| Total Equity | $4.3B | $10.6B | $19.2B | $21.8B | $22.3B | |
| Total Debt | $1.2B | $2.7B | $45.6B | $37.1B | $38.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.8B | $2.7B | $3B | $901M | $1.1B | |
| Cash From Investing | $75M | $2.4B | -$10.2B | -$358M | -$3.7B | |
| Cash From Financing | -$2.7B | -$4.7B | $7.1B | -$426M | $2.6B | |
| Free Cash Flow | $1.9B | $1.2B | $1.5B | $485M | $678M | |
FCNCA
Sector
Market Cap
$24.1B
$603.7M
Price % of 52-Week High
74.31%
84.45%
Dividend Yield
0.4%
2.05%
Shareholder Yield
--
3.98%
1-Year Price Total Return
5.01%
9.07%
Beta (5-Year)
0.664
0.555
Dividend yield:
0.4%
Annualized payout:
$6.87
Payout ratio:
4.71%
Growth streak:
8 years
Technicals
8-day SMA
Buy
Level
$1,755.11
200-day SMA
Sell
Level
$1,991.25
Bollinger Bands (100)
Sell
Level
1803.27 - 2191.47
Chaikin Money Flow
Buy
Level
57.6K
20-day SMA
Buy
Level
$1,709.36
Relative Strength Index (RSI14)
Buy
Level
52.98
ADX Line
Buy
Level
18.18
Williams %R
Sell
Level
-18.4613
50-day SMA
Sell
Level
$1,840.62
MACD (12, 26)
Sell
Level
-15.87
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Neutral
Level
2.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.7038)
Sell
CA Score
(Annual)
Level (-2.1063)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (2.0622)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.
Stock Forecast FAQ
In the current month, FCNCA has received 3 Buy ratings 4 Hold ratings, and 0 Sell ratings. The FCNCA average analyst price target in the past 3 months is $2,191.25.
-
Where Will First Citizens BancShares Stock Be In 1 Year?
According to analysts, the consensus estimate is that First Citizens BancShares share price will rise to $2,191.25 per share over the next 12 months.
-
What Do Analysts Say About First Citizens BancShares?
Analysts are divided on their view about First Citizens BancShares share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that First Citizens BancShares is a Sell and believe this share price will drop from its current level to $1,900.00.
-
What Is First Citizens BancShares's Price Target?
The price target for First Citizens BancShares over the next 1-year time period is forecast to be $2,191.25 according to 7 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is FCNCA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for First Citizens BancShares is a Hold. 4 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of FCNCA?
You can purchase shares of First Citizens BancShares via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase First Citizens BancShares shares.
-
What Is The First Citizens BancShares Share Price Today?
First Citizens BancShares was last trading at $1,775.93 per share. This represents the most recent stock quote for First Citizens BancShares. Yesterday, First Citizens BancShares closed at $1,793.05 per share.
-
How To Buy First Citizens BancShares Stock Online?
In order to purchase First Citizens BancShares stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
